Journal
CHEMICAL REVIEWS
Volume 118, Issue 3, Pages 989-1068Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acs.chemrev.6b00801
Keywords
-
Categories
Funding
- National Institute of General Medical Sciences of the U.S. National Institutes of Health [R01GM103893, R01GM122749]
Ask authors/readers for more resources
Post-translational modifications of histones by protein methyltransferases (PMTs) and histone demethylases (KDMs) play an important role in the regulation of gene expression and transcription and are implicated in cancer and many other diseases. Many of these enzymes also target various nonhistone proteins impacting numerous crucial biological pathways. Given their key biological functions and implications in human diseases, there has been a growing interest in assessing these enzymes as potential therapeutic targets. Consequently, discovering and developing inhibitors of these enzymes has become a very active and fast-growing research area over the past decade. In this review, we cover the discovery, characterization, and biological application of inhibitors of PMTs and KDMs with emphasis on key advancements in the field. We also discuss challenges, opportunities, and future directions in this emerging, exciting research field.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available